Your browser doesn't support javascript.
loading
Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical Trial.
Landen, Charles N; Molinero, Luciana; Hamidi, Habib; Sehouli, Jalid; Miller, Austin; Moore, Kathleen N; Taskiran, Cagatay; Bookman, Michael; Lindemann, Kristina; Anderson, Charles; Berger, Regina; Myers, Tashanna; Beiner, Mario; Reid, Thomas; Van Nieuwenhuysen, Els; Green, Andrew; Okamoto, Aikou; Aghajanian, Carol; Thaker, Premal H; Blank, Stephanie V; Khor, Victor K; Chang, Ching-Wei; Lin, Yvonne G; Pignata, Sandro.
Affiliation
  • Landen CN; Gynecologic Oncology Group Foundation (GOG-F) and Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, Virginia.
  • Molinero L; Oncology Biomarker Development, Genentech, Inc., South San Francisco, California.
  • Hamidi H; Oncology Biomarker Development, Genentech, Inc., South San Francisco, California.
  • Sehouli J; Arbeitsgemeinschaft Gynaekologische Onkologie (AGO)/Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie (North-Eastern German Society of Gynaecologic Oncology; NOGGO) and Charité-Medical University of Berlin (Campus Virchow Klinikum), Berlin, Germany.
  • Miller A; GOG-F and Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Moore KN; GOG-F and Stephenson Cancer Center at the University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, and Sarah Cannon Research Institute, Nashville, Tennessee.
  • Taskiran C; Turkish Society of Gynecologic Oncology (TRSGO) and Koc University School of Medicine and VKV American Hospital, Istanbul, Turkey.
  • Bookman M; GOG-F and Kaiser Permanente Northern California, San Francisco, California.
  • Lindemann K; Nordic Society of Gynaecological Oncology (NSGO) and Department of Gynecological Oncology, Division of Cancer Medicine, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Anderson C; GOG-F and Willamette Valley Cancer Institute, Eugene, Oregon.
  • Berger R; AGO-Austria and Department for Gynecology and Obstetrics, Innsbruck Medical University, Innsbruck, Austria.
  • Myers T; GOG-F and Baystate Medical Center, Springfield, Massachusetts.
  • Beiner M; Israeli Society of Gynecologic Oncology (ISGO) and Gynecologic Oncology Division, Meir Medical Center, Tel Aviv University, Kfar Saba, Israel.
  • Reid T; GOG-F and Kettering Medical Center, Kettering, Ohio.
  • Van Nieuwenhuysen E; Belgium and Luxembourg Gynaecological Oncology Group (BGOG) and UZ Leuven Gasthuisberg, Leuven, Belgium.
  • Green A; GOG-F and Northeast Georgia Medical Center, Gainesville, Georgia.
  • Okamoto A; Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan.
  • Aghajanian C; GOG-F and Memorial Sloan Kettering Cancer Center, New York, New York.
  • Thaker PH; GOG-F and Washington University School of Medicine, St. Louis, Missouri.
  • Blank SV; GOG-F and Icahn School of Medicine at Mount Sinai, New York, New York.
  • Khor VK; Product Development Oncology, Genentech, Inc., South San Francisco, California.
  • Chang CW; Personalized Healthcare and Early Development Oncology Biostatistics, Genentech, Inc., South San Francisco, California.
  • Lin YG; Product Development Oncology, Genentech, Inc., South San Francisco, California.
  • Pignata S; Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO) and Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Napoli, Italy.
Clin Cancer Res ; 29(9): 1698-1707, 2023 05 01.
Article in En | MEDLINE | ID: mdl-36595569
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / B7-H1 Antigen Type of study: Clinical_trials / Diagnostic_studies Limits: Female / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / B7-H1 Antigen Type of study: Clinical_trials / Diagnostic_studies Limits: Female / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2023 Type: Article